Legal News & Analysis on Litigation, Policy, Deals : Law360

Top News

Mapping The Top Trials To Know In The Opioid Litigation Wave

By Jeff Overley and Ben Jay

Opioid crisis lawsuits against major companies in the pharmaceutical supply chain are heating up in large numbers, producing a byzantine brew of battles in courts all across America. Here, Law360 provides a map that will continue to track completed, ongoing and upcoming trials.

Health Co. Execs Convicted In $100M Adderall Sales Scheme

By Lauren Berg

A San Francisco federal jury weighing a first-of-its-kind case on Tuesday convicted two digital healthcare company executives of scheming to sell Adderall through deceptive advertising, allegedly bringing in $100 million in illicit profits.

Opioids Didn't Weigh Heavily In Finances, Hospital Execs Say

By Cara Salvatore

A Florida state court jury heard the start of major pharmacy chains' defense case Friday over allegations that they fueled the opioid crisis and sent Florida hospitals' costs soaring, with testimony from former hospital executives saying the cost of opioid treatment didn't loom large in their financial decisions.

Philly Accuses PBMs Of Knowingly Enabling Opioid Crisis

By Hailey Konnath

Philadelphia on Thursday sued CVS Caremark, Express Scripts and Optum, accusing the pharmacy benefit managers of contributing to the city's opioid epidemic via deceptive marketing and conspiring with drugmakers to increase the sale of OxyContin and other prescription opioids.

Pharmacies Say $1.5B Damages Too Much In Fla. Opioid Suit

By Cara Salvatore

CVS, Walgreens and Walmart on Wednesday grilled an economics expert witness over his opinion that they owe as much as $1.5 billion to a group of Florida hospitals that treated opioid-harmed patients, with defense counsel suggesting damages shouldn't be based on the full sticker price of the medical care.

3 Pharmaceutical Firms Will Pay $4M To Tribes In Opioid MDL

By George Woolston

Indivior, Sun Pharmaceuticals and Zydus Pharmaceuticals have inked deals to compensate tribes for their role in the opioid crisis, according to stipulated dismissals entered on Wednesday in Ohio federal court.

Expert Analysis

Big Cos. Shouldn't Cry 'Settlement Pressure' To Justify Appeal

By J.B. Heaton

The Sixth Circuit was correct to find that intense pressure to settle doesn't earn opioid case defendants Walgreens and Walmart an interlocutory appeal or new trial on liability, as that argument applies only when a defendant is risk averse, a notion not suited to large public corporations, says J.B. Heaton at One Hat Research.

Amid Historic Spending, Congress Should Strengthen FCA

By Jeb White

Notwithstanding the misleadingly rosy picture painted by the U.S. Department of Justice’s fiscal year 2021 False Claims Act recovery statistics, Congress should close legislative gaps that deter whistleblower actions, especially in light of increasingly high government spending and adjacent opportunities to misuse public funds, says Jeb White at Taxpayers Against Fraud.

What Cos. Can Learn From The 2021 FCA Recovery Statistics

By Suzanne Jaffe Bloom, Benjamin Sokoly and Jack Cartwright

Attorneys at Winston unpack the recently released U.S. Department of Justice False Claims Act recovery statistics for fiscal year 2021, discuss how they compare to prior years and what companies in an expanding array of industries should expect next.

MORE COVERAGE

October 30, 2025 12:07 AM

Pharmacies Say $1.5B Damages Too Much In Fla. Opioid Suit

October 29, 2025 05:53 PM

3 Pharmaceutical Firms Will Pay $4M To Tribes In Opioid MDL

October 28, 2025 04:05 PM

4th Circ. Overturns Landmark W.Va. Opioid Verdict

October 14, 2025 03:58 PM

Judges Back Ga. County's Use Of Outside Attys In Opioid Suit

October 9, 2025 09:01 PM

McKesson Aims To Escape Dealer Claims In Overdose Death

September 30, 2025 11:22 PM